Wainzua (Eplontersen) Recommended for Approval in the EU by Chmp for the Treatment of Adults With Polyneuropathy Associated With Hereditary Transthyretin-Mediated Amyloidosis
Wainzua (Eplontersen) 已經被歐盟CHMP推薦批准，用於治療與遺傳性前轉甲狀腺激素介導的澱粉樣蛋白沉積相關的多發性神經病變成人病例
